Fail Fast, Fail Cheap: In-Silico Toxicology Pipelines for Early Drug Candidate
Drug discovery is basically a casino where the house almost always wins. Around more than 90% of drug projects never make it to patients, and the price of failure climbs steeply the further along you go. Flop early in discovery? That’s about a million dollars down the drain. Flop